Gilead Stock News

Louisiana State Employees Retirement System lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 0.1% in the third quarter, HoldingsChannel.com reports. The firm owned 142,900 shares of the biopharmaceutical companys stock after selling 200 shares during the period. Louisiana State Employees Retirement Systems holdings in Gilead Sciences were worth $9,981,000 as of its []

Iowa State Bank increased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 2.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 39,038 shares of the biopharmaceutical companys stock after buying an additional 899 shares during the period. Iowa State Banks holdings in []

(RTTNews) - Pharmaceutical firm Gilead Sciences, Inc. (GILD), on Friday, said it has submitted a Biologics License Application or BLA, to the U.S. Food and Drug Administration or FDA, for bulevirtide 2 mg injection, a potential first-in-class antiviral medicine for the treatment of chronic hepatitis delta virus or HDV infection in adults with

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for bulevirtide for injection (2 mg), a potential first-in-class antiviral medicine for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease; bulevirtide has been granted Breakthrough Therapy and Orphan Drug designations by the FDA. Bulevirtide is an

Gilead Sciences Inc (NASDAQ: GILD) has submitted a marketing application to FDA for bulevirtide for injection (2 mg) for chronic hepatitis delta virus (HDV) infection in adults with compensated liv

Gilead (GILD) exercises options to Arcus' anti-TIGIT Program (domvanalimab and AB308), etrumadenant (A2a/A2b Adenosine Receptor Antagonist), and quemliclustat (small Molecule CD73 Inhibitor).

Guild Esports plc (LON:GILD), a global teams organisation and lifestyle brand, has announce the signing of Lennard Sill (Rezon) as the newest member of its Fortnite team. Rezon, from Germany, is a 17-time tournament winner with earnings of over $300,000. He has consistently ranked within the top 10 in Fortnite Champion Series (FNCS) tournaments this []

Europe Pharmaceutical Market: Overview The Europe pharmaceutical market has been anticipated to grow at a significant speed in the forthcoming years. This market has been driven by the rising rate of healthcare expenditure, the emergence of biosimilars and biologics, and increasing

The average yield for 9 large pharmaceutical companies is 3.27% Related Stocks: LLY , GSK , BMY , PFE , AZN , ABBV , GILD , JNJ , SNY , PJP ,

Wedbush Securities Inc. trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD) by 7.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,161 shares of the biopharmaceutical companys stock after selling 2,774 shares during the quarter. Wedbush Securities Inc.s holdings in Gilead []

Of the top nine members of Big Pharma with high dividend yields, Eli Lilly and Co. ( LLY , Financial) brings up the rear at 1.32%. But that hardly tells the full story.